On Friday, June 12, the European Medicines Agency (EMA) held an ad-hoc meeting of its Executive Steering Group on Shortages and Safety of Medicinal Products. While this body oversees both conventional and natural medicinal frameworks under European Regulation, the core focus remains tightly fixed on supply chain resilience, safety, and mitigation strategies for raw materials—an ongoing hot-button issue for the standardization of European phytomedicines and global botanical sourcing. This episode of This Week in Botanical Medicine examines the strategic Issues facing public access to pharmaceuticals and botanical medicines in the European Union.
Keep up with regular writings and reflections by following Stephanie on Substack at
https://substack.com/@deeplyrootedmedwithstephanieg
June Special at The Living Pharmacy School! Learn all about botanical medicine for skin health and wellness, please go to
https://livingpharmacy.teachable.com/l/pdp/living-pharmacy-for-skin-health
Immerse yourself in the relationship between nature and tradition by joining the 9-part CreationCentered Herbalism course at
https://livingpharmacy.teachable.com/l/pdp/creation-centered-herbalism
Begin your formal clinical herbalism journey and enroll in Living Pharmacy: From Seed to Bodyto Soul at
https://livingpharmacy.teachable.com/l/pdp/living-pharmacy-from-seed-to-body-to-soul
#StraitOfHormuz #SupplyChainCrisis #HerbalMedicine #LivingPharmacy